Catalyst Wire Dossier Catalyst Wire Dossier

Izelvay

avacincaptad pegol · Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Izelvay, covering 2025-02-04 to 2025-02-04. Get the full timeline:

Most recent: EMA Application withdrawn: Izelvay (avacincaptad pegol) — Astellas Pharma Europe B.V.

See pricing